Key result
Elevated ADAR1 levels in breast cancer cells coordinate with ADAR2 to regulate Ctn RNA stability and are associated with lower patient survival.
Answers are grounded in this paper and cite their sources.
Adenosine deaminases acting on RNA (ADARs) are proteins that catalyse widespread A-to-I editing within RNA sequences. We recently reported that ADAR2 edits and stabilizes nuclear-retained Cat2 transcribed nuclear RNA (Ctn RNA). Here, we report that ADAR1 coordinates with ADAR2 to regulate editing and stability of Ctn RNA. We observe an RNA-dependent interaction between ADAR1 and ADAR2. Furthermore, ADAR1 negatively regulates interaction of Ctn RNA with RNA-destabilizing proteins. We also show that breast cancer (BC) cells display elevated ADAR1 but not ADAR2 levels, compared to nontumourigenic cells. Additionally, BC patients with elevated levels of ADAR1 show low survival. Our findings provide insights into overlapping substrate preferences of ADARs and potential involvement of ADAR1 in BC.
No takes yet. Share an insight, caveat, or question.
Anantharaman et al. (2017) studied Breast cancer. Elevated ADAR1 levels vs. Nontumourigenic cells / low ADAR1 levels was evaluated on Ctn RNA editing and stability, and patient survival. Elevated ADAR1 levels in breast cancer cells coordinate with ADAR2 to regulate Ctn RNA stability and are associated with lower patient survival.
Synapse has enriched 10 related papers. Consider them for comparative context: